Shakti Chakraborty, group president (India and CIS) of Lupin, talks to NDTV Profit about the company's strategic tie-up with Merck Sharp & Dohme for a pneumonia prevention vaccine. Mr Chakraborty says the company is likely to see tremendous growth with the vaccine as awareness grows about pneumococcal infection prevention.